419 related articles for article (PubMed ID: 17109648)
1. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
2. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
6. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
9. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Schlosburg JE; Kinsey SG; Lichtman AH
AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
[TBL] [Abstract][Full Text] [Related]
10. Endogenous cannabinoids: structure and metabolism.
Bisogno T
J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
[TBL] [Abstract][Full Text] [Related]
11. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system and pain.
Guindon J; Hohmann AG
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
16. Anandamide uptake explained?
Fowler CJ
Trends Pharmacol Sci; 2012 Apr; 33(4):181-5. PubMed ID: 22297258
[TBL] [Abstract][Full Text] [Related]
17. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
19. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
20. Modulation of anxiety through blockade of anandamide hydrolysis.
Kathuria S; Gaetani S; Fegley D; Valiño F; Duranti A; Tontini A; Mor M; Tarzia G; La Rana G; Calignano A; Giustino A; Tattoli M; Palmery M; Cuomo V; Piomelli D
Nat Med; 2003 Jan; 9(1):76-81. PubMed ID: 12461523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]